Listen " Can Fractyl Labs and Cala Health go where only drugs have gone before? "
Episode Synopsis
In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week's Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.
We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they're making in developing a device to treat diabetes.
In a second interview, Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s clinical success and how the start-up is working through COVID-19.
Finally, Chris and Tom hint at an upcoming event for the DTW community.
More episodes of the podcast DeviceTalks Podcast Network
May the best robot win – Medtronic’s Hugo RAS ready to compete for surgical business in the US
19/12/2025
Ray Cohen on How to Successfully Build and Exit a MedTech; Talking Revolution with Sarah Matt, MD
12/12/2025
How Enovis is unlocking better bracing with innovative materials, patient comfort & next-gen tech
09/12/2025
How amazing tech – like Medtronic’s LINQ and beyond – can, will and must change health care
05/12/2025
Where is surgical robotics headed? Listen to these leaders- Moon’s Osdoit, Intuitive’s Jeddi
26/11/2025
J&J’s Schmid, Stanford’s Makower on helping MedTech find a higher gear for innovation and growth
21/11/2025
How Enovis is accelerating orthopedic recovery with bone stimulation and patient-centered innovation
18/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.